AngioDynamics, Inc. (ANGO)

AngioDynamics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AngioDynamics, Inc. (ANGO) is a Medical - Instruments & Supplies company based in US with a market capitalization of $479.8M. Revenue declined 3.8% year-over-year and free cash flow was negative at -$14.6M. This page tracks ANGO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 748 employees · IPO Jun 1, 2004

Valuation

Valuation & price

$10.77as of May 17, 2026· -21.2% vs 52w high

P/E ratio

Latest-FY diluted EPS

2.62

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$13.64$11.02$8.40Jul 25Dec 25Jul 26
$8.4052-week range$13.66
Loading valuation history…

Fundamentals

Key fundamentals

$479.8M

Market cap

-3.8%

Revenue growth (YoY)

53.9%

Gross margin

-$14.6M

Free cash flow (USD)

-$55.9M

Net debt

Net cash position

2.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$353.7M$292.5M

Free cash flow by year

20162025

$39.6M-$14.6M

Gross margin by year

20212025

53.9%53.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 2, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventApr 23, 2026Filing

    Patent Infringement Lawsuit

  • 8-K eventApr 2, 2026Filing

    Earnings Release

  • Quarterly reportApr 2, 2026Filing

    10-Q Filed

Questions

Frequently asked questions

What is AngioDynamics, Inc.'s market cap?

AngioDynamics, Inc. (ANGO) has a market capitalization of $479.8M.

What is ANGO's P/E ratio?

A meaningful P/E ratio is not available for ANGO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ANGO's price-to-book (P/B) ratio?

ANGO trades at 2.62 times book value per share.

Are insiders buying ANGO stock?

SEC Form 4 filings show no open-market insider buys at AngioDynamics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.